{"nct_id":"NCT02853331","title":"Study to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Axitinib Versus Sunitinib Monotherapy in Participants With Renal Cell Carcinoma (MK-3475-426/KEYNOTE-426)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2016-09-16","start_date_type":"ACTUAL","primary_completion_date":"2018-10-18","primary_completion_date_type":"ACTUAL","completion_date":"2025-12-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}